Drug ID: | NPD6398 |
Drug Name: | |
Molecular Formula: | C25H36O4 |
Canonical SMILES: | CCCCCCC(c1cc(O)c2c(c1)OC([C@H]1[C@H]2CC(=CC1)C(=O)O)(C)C)(C)C |
Standard InCHI: | InChI=1S/C25H36O4/c1-6-7-8-9-12-24(2,3)17-14-20(26)22-18-13-16(23(27)28)10-11-19(18)25(4,5)29-21(22)15-17/h10,14-15,18-19,26H,6-9,11-13H2,1-5H3,(H,27,28)/t18-,19-/m1/s1 |
Standard InCHIKey: | YCHYFHOSGQABSW-RTBURBONSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DCL000849; DIB008371 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 3083542 |
ChEBI | |
CAS Number |
Molecular Weight | 400.26 |
ALogP | -0.0688 |
MLogP | 3.77 |
XLogP | 7.006 |
HDA | 2 |
HBD | 2 |
Rotatable Bonds | 14 |
TPSA | 66.76 |
RO5 Violation | 1 |